CY2337B1 - Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 invection. - Google Patents

Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 invection.

Info

Publication number
CY2337B1
CY2337B1 CY0300023A CY0300023A CY2337B1 CY 2337 B1 CY2337 B1 CY 2337B1 CY 0300023 A CY0300023 A CY 0300023A CY 0300023 A CY0300023 A CY 0300023A CY 2337 B1 CY2337 B1 CY 2337B1
Authority
CY
Cyprus
Prior art keywords
treatment
prophylaxis
invection
herpes virus
purine derivatives
Prior art date
Application number
CY0300023A
Other languages
English (en)
Inventor
Hodge Richard Anthony Vere
Original Assignee
Novartis Int Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Int Pharm Ltd filed Critical Novartis Int Pharm Ltd
Publication of CY2337B1 publication Critical patent/CY2337B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CY0300023A 1993-11-12 2003-03-11 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 invection. CY2337B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939323404A GB9323404D0 (en) 1993-11-12 1993-11-12 Pharmaceuticals

Publications (1)

Publication Number Publication Date
CY2337B1 true CY2337B1 (en) 2004-02-06

Family

ID=10745092

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0300023A CY2337B1 (en) 1993-11-12 2003-03-11 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 invection.

Country Status (18)

Country Link
US (1) US6051579A (de)
EP (1) EP0728002B1 (de)
JP (1) JP3821840B2 (de)
KR (1) KR100341736B1 (de)
CN (1) CN1071572C (de)
AT (1) ATE210445T1 (de)
AU (1) AU696833B2 (de)
CA (1) CA2176392C (de)
CY (1) CY2337B1 (de)
DE (1) DE69429447T2 (de)
DK (1) DK0728002T3 (de)
ES (1) ES2169117T3 (de)
GB (1) GB9323404D0 (de)
HK (1) HK1012234A1 (de)
PT (1) PT728002E (de)
SI (1) SI0728002T1 (de)
WO (1) WO1995013074A1 (de)
ZA (1) ZA948908B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475253B2 (en) 1996-09-11 2002-11-05 3M Innovative Properties Company Abrasive article and method of making
US20040097528A1 (en) * 2002-08-26 2004-05-20 Ben-Zion Dolitzky Crystalline solid famciclovir forms I, II, III and preparation thereof
EP1932911A4 (de) * 2005-09-08 2009-10-28 Univ Osaka Res Found Promotor zur einführung eines gens in lymphozyten oder blutzellen und anwendung davon

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
DE3582399D1 (de) * 1984-09-20 1991-05-08 Beecham Group Plc Purin-derivate und ihre pharmazeutische verwendung.
EP0216459B1 (de) * 1985-07-27 1990-05-16 Beecham Group Plc 9-Substituierte Guaninmonohydrate
GB8628826D0 (en) * 1986-12-02 1987-01-07 Beecham Group Plc Pharmaceutical products
US4795799A (en) * 1987-09-08 1989-01-03 Phillips Petroleum Company Production of aromatic sulfide/ketone polymers with alkali metal carbonate
CA2042931A1 (en) * 1990-05-24 1991-11-25 Robert Zahler Fluorinated bis (hydroxymethyl) cyclobutyl purines and pyrimidines
GB9015051D0 (en) * 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment

Also Published As

Publication number Publication date
DK0728002T3 (da) 2002-04-08
US6051579A (en) 2000-04-18
JP3821840B2 (ja) 2006-09-13
DE69429447D1 (de) 2002-01-24
DE69429447T2 (de) 2002-07-25
KR100341736B1 (ko) 2002-11-23
AU696833B2 (en) 1998-09-17
AU8149194A (en) 1995-05-29
PT728002E (pt) 2002-05-31
CN1136277A (zh) 1996-11-20
EP0728002A1 (de) 1996-08-28
SI0728002T1 (en) 2002-04-30
CA2176392C (en) 2005-11-08
CA2176392A1 (en) 1995-05-18
HK1012234A1 (en) 1999-07-30
ES2169117T3 (es) 2002-07-01
ZA948908B (en) 1995-08-17
ATE210445T1 (de) 2001-12-15
JPH09511218A (ja) 1997-11-11
EP0728002B1 (de) 2001-12-12
CN1071572C (zh) 2001-09-26
GB9323404D0 (en) 1994-01-05
WO1995013074A1 (en) 1995-05-18

Similar Documents

Publication Publication Date Title
HUT53522A (en) Process for producing pharmaceutical compositions comprising purine derivatives
AU8447991A (en) Antineoplastic effect potentiator and antineoplastic agent
HK1012234A1 (en) Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection
CY2525B1 (en) Use of penciclovir for the treatment of human herpes-virus-8
CY2338B1 (en) Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections.
CA2207503A1 (en) Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections
IL111138A (en) Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia